Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth | 40 | 2002 | 137 | 2.510 |
Why?
|
| Calcium | 24 | 2004 | 555 | 1.320 |
Why?
|
| Calcium Channels | 11 | 2007 | 101 | 1.100 |
Why?
|
| Fatty Acids | 9 | 2002 | 190 | 0.910 |
Why?
|
| Potassium Channels | 9 | 2001 | 53 | 0.840 |
Why?
|
| Ion Channels | 16 | 1997 | 88 | 0.830 |
Why?
|
| Bufo marinus | 36 | 2004 | 46 | 0.650 |
Why?
|
| Potassium Channels, Calcium-Activated | 3 | 2002 | 13 | 0.600 |
Why?
|
| Cell Membrane | 11 | 2007 | 486 | 0.600 |
Why?
|
| Ion Channel Gating | 5 | 2007 | 44 | 0.440 |
Why?
|
| Potassium | 16 | 1991 | 100 | 0.440 |
Why?
|
| Membrane Potentials | 20 | 2007 | 137 | 0.420 |
Why?
|
| Stomach | 18 | 2001 | 83 | 0.420 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2002 | 47 | 0.370 |
Why?
|
| Acetylcholine | 11 | 1992 | 41 | 0.370 |
Why?
|
| Electric Conductivity | 16 | 2004 | 52 | 0.310 |
Why?
|
| Caffeine | 5 | 2007 | 47 | 0.310 |
Why?
|
| Muscle Contraction | 13 | 2000 | 197 | 0.300 |
Why?
|
| Patch-Clamp Techniques | 11 | 2007 | 126 | 0.290 |
Why?
|
| Fluorescence | 2 | 2004 | 83 | 0.280 |
Why?
|
| Animals | 49 | 2007 | 19651 | 0.260 |
Why?
|
| Receptors, Purinergic P2 | 3 | 2001 | 10 | 0.260 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2004 | 57 | 0.250 |
Why?
|
| In Vitro Techniques | 17 | 2007 | 471 | 0.250 |
Why?
|
| Electrophysiology | 13 | 2002 | 87 | 0.250 |
Why?
|
| Gastric Mucosa | 3 | 2001 | 51 | 0.220 |
Why?
|
| Cations | 2 | 2002 | 63 | 0.220 |
Why?
|
| Cytosol | 1 | 2004 | 171 | 0.210 |
Why?
|
| Anions | 1 | 2002 | 33 | 0.200 |
Why?
|
| Arteries | 1 | 2002 | 76 | 0.190 |
Why?
|
| Bile Acids and Salts | 1 | 2002 | 20 | 0.190 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 203 | 0.180 |
Why?
|
| Cytoplasm | 1 | 1999 | 270 | 0.150 |
Why?
|
| Acyl Coenzyme A | 2 | 1995 | 9 | 0.150 |
Why?
|
| Receptors, Muscarinic | 4 | 1990 | 14 | 0.150 |
Why?
|
| Lipids | 2 | 2002 | 300 | 0.140 |
Why?
|
| Muscarine | 5 | 1990 | 5 | 0.140 |
Why?
|
| Amines | 3 | 2002 | 29 | 0.130 |
Why?
|
| Rabbits | 4 | 2002 | 322 | 0.120 |
Why?
|
| Action Potentials | 7 | 1988 | 101 | 0.110 |
Why?
|
| Calcium Channel Agonists | 2 | 2007 | 10 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 1990 | 20 | 0.110 |
Why?
|
| Myristic Acid | 3 | 2002 | 8 | 0.110 |
Why?
|
| Diglycerides | 3 | 1992 | 23 | 0.110 |
Why?
|
| Isoproterenol | 4 | 1992 | 34 | 0.100 |
Why?
|
| Arachidonic Acid | 3 | 2002 | 34 | 0.100 |
Why?
|
| Fluorescent Dyes | 3 | 2004 | 196 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 1992 | 90 | 0.090 |
Why?
|
| Substance P | 3 | 1989 | 44 | 0.090 |
Why?
|
| Physical Stimulation | 3 | 1995 | 29 | 0.090 |
Why?
|
| Esophagus | 1 | 1990 | 50 | 0.080 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 23 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1989 | 56 | 0.080 |
Why?
|
| Sphingosine | 2 | 2002 | 20 | 0.080 |
Why?
|
| Electrochemistry | 2 | 2002 | 27 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2002 | 2093 | 0.080 |
Why?
|
| Adenosine Triphosphate | 3 | 2001 | 289 | 0.080 |
Why?
|
| Glycerides | 1 | 1988 | 11 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 1988 | 41 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2007 | 88 | 0.070 |
Why?
|
| Cell Membrane Permeability | 5 | 1997 | 39 | 0.070 |
Why?
|
| Tetraethylammonium Compounds | 4 | 1990 | 4 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2007 | 153 | 0.060 |
Why?
|
| Muscles | 3 | 1983 | 173 | 0.060 |
Why?
|
| Sodium | 6 | 1994 | 60 | 0.060 |
Why?
|
| Xanthenes | 1 | 2004 | 9 | 0.060 |
Why?
|
| Aniline Compounds | 1 | 2004 | 35 | 0.060 |
Why?
|
| Cyclic AMP | 4 | 1994 | 142 | 0.060 |
Why?
|
| Receptors, Purinergic P2X7 | 2 | 2001 | 9 | 0.060 |
Why?
|
| Myristic Acids | 2 | 1995 | 5 | 0.060 |
Why?
|
| Ryanodine | 3 | 2007 | 10 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 2001 | 81 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 806 | 0.050 |
Why?
|
| Trimethyl Ammonium Compounds | 1 | 2002 | 1 | 0.050 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2002 | 2 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 392 | 0.050 |
Why?
|
| Oleic Acid | 1 | 2002 | 21 | 0.050 |
Why?
|
| Parasympathomimetics | 2 | 1985 | 2 | 0.050 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2002 | 29 | 0.050 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2002 | 29 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 41 | 0.050 |
Why?
|
| Time Factors | 4 | 2002 | 3617 | 0.050 |
Why?
|
| Mesenteric Arteries | 1 | 2002 | 9 | 0.050 |
Why?
|
| Kinetics | 4 | 1991 | 751 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2002 | 90 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2002 | 142 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 365 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2001 | 29 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 32 | 0.050 |
Why?
|
| Carbachol | 3 | 1994 | 17 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2001 | 88 | 0.050 |
Why?
|
| Manganese | 4 | 1987 | 24 | 0.050 |
Why?
|
| Sarcolemma | 1 | 1980 | 10 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2002 | 400 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 1999 | 63 | 0.040 |
Why?
|
| Tetraethylammonium | 2 | 1990 | 8 | 0.040 |
Why?
|
| Cell Separation | 2 | 1994 | 145 | 0.040 |
Why?
|
| Computer Simulation | 1 | 1999 | 458 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 654 | 0.030 |
Why?
|
| Atropine | 2 | 1990 | 13 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1995 | 18 | 0.030 |
Why?
|
| Albumins | 1 | 1995 | 34 | 0.030 |
Why?
|
| Fura-2 | 1 | 1994 | 8 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 1994 | 23 | 0.030 |
Why?
|
| Lipid Bilayers | 1 | 1994 | 50 | 0.030 |
Why?
|
| Aluminum Compounds | 1 | 1993 | 10 | 0.030 |
Why?
|
| Aluminum | 1 | 1993 | 14 | 0.030 |
Why?
|
| Fluorides | 1 | 1993 | 24 | 0.030 |
Why?
|
| Cats | 3 | 1990 | 81 | 0.020 |
Why?
|
| Muscarinic Antagonists | 1 | 1990 | 32 | 0.020 |
Why?
|
| Cadmium | 1 | 1990 | 12 | 0.020 |
Why?
|
| Adenine Nucleotides | 1 | 1969 | 4 | 0.020 |
Why?
|
| Models, Biological | 1 | 1995 | 1143 | 0.020 |
Why?
|
| Rats | 2 | 2007 | 1910 | 0.020 |
Why?
|
| Cations, Divalent | 2 | 1997 | 22 | 0.020 |
Why?
|
| Electric Stimulation | 4 | 1997 | 131 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1969 | 147 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1988 | 98 | 0.020 |
Why?
|
| Tetracaine | 1 | 2007 | 7 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2007 | 17 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 2007 | 3 | 0.020 |
Why?
|
| Cresols | 1 | 2007 | 5 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2007 | 12 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 1987 | 8 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2007 | 13 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2007 | 40 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2007 | 56 | 0.020 |
Why?
|
| Physalaemin | 1 | 1986 | 1 | 0.020 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 1986 | 11 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1986 | 17 | 0.020 |
Why?
|
| Heart Atria | 1 | 2007 | 135 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2007 | 145 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2007 | 253 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 349 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1986 | 418 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1980 | 14 | 0.010 |
Why?
|
| Chlorides | 1 | 1980 | 32 | 0.010 |
Why?
|
| Barium | 2 | 1991 | 5 | 0.010 |
Why?
|
| Quinolinium Compounds | 1 | 1997 | 1 | 0.010 |
Why?
|
| Benzoxazoles | 1 | 1997 | 5 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 1997 | 18 | 0.010 |
Why?
|
| Meglumine | 1 | 1997 | 18 | 0.010 |
Why?
|
| Xenopus | 1 | 1997 | 54 | 0.010 |
Why?
|
| Microinjections | 1 | 1997 | 67 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1977 | 19 | 0.010 |
Why?
|
| Feedback | 2 | 1994 | 87 | 0.010 |
Why?
|
| Oocytes | 1 | 1997 | 193 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 689 | 0.010 |
Why?
|
| Gene Expression | 1 | 1997 | 809 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 1994 | 14 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1994 | 26 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1994 | 48 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 23 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 10292 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 1137 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 1971 | 13 | 0.010 |
Why?
|
| Ankle | 1 | 1971 | 22 | 0.010 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1991 | 1 | 0.010 |
Why?
|
| Dihydropyridines | 1 | 1991 | 1 | 0.010 |
Why?
|
| Movement | 1 | 1971 | 149 | 0.010 |
Why?
|
| Magnesium | 1 | 1991 | 52 | 0.010 |
Why?
|
| Phrenic Nerve | 1 | 1969 | 2 | 0.010 |
Why?
|
| Theophylline | 1 | 1969 | 9 | 0.010 |
Why?
|
| Diaphragm | 1 | 1969 | 21 | 0.010 |
Why?
|
| Hypertension | 1 | 1994 | 568 | 0.000 |
Why?
|
| Sincalide | 1 | 1986 | 1 | 0.000 |
Why?
|
| Bombesin | 1 | 1986 | 2 | 0.000 |
Why?
|
| Secretin | 1 | 1986 | 4 | 0.000 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1986 | 23 | 0.000 |
Why?
|
| Mathematics | 1 | 1985 | 32 | 0.000 |
Why?
|
| Markov Chains | 1 | 1985 | 34 | 0.000 |
Why?
|
| Dopamine | 1 | 1986 | 102 | 0.000 |
Why?
|
| Probability | 1 | 1985 | 166 | 0.000 |
Why?
|
| Humans | 1 | 1990 | 59360 | 0.000 |
Why?
|
| Spinal Nerve Roots | 2 | 1971 | 17 | 0.000 |
Why?
|
| Neural Conduction | 1 | 1971 | 29 | 0.000 |
Why?
|
| Rest | 1 | 1971 | 44 | 0.000 |
Why?
|
| Tendons | 1 | 1971 | 23 | 0.000 |
Why?
|
| Decerebrate State | 1 | 1970 | 1 | 0.000 |
Why?
|
| Muscle Spindles | 1 | 1970 | 1 | 0.000 |
Why?
|
| Muscle Denervation | 1 | 1970 | 4 | 0.000 |
Why?
|
| Reflex | 1 | 1970 | 27 | 0.000 |
Why?
|
| Peripheral Nerves | 1 | 1970 | 30 | 0.000 |
Why?
|